Telmiline 40mg (Telmisartan)

Adult dose

For essential hypertension, administer 40 mg of Telmisartan orally once daily with water, without regard to meals. It may be effective at 20 mg once daily for some patients. If necessary, the dose can be increased up to 80 mg once daily, with maximum blood pressure-lowering effects observed 4-8 weeks after dose increase. For reduction of cardiovascular disease risk, 80 mg once daily is recommended.

This medicine can cause severe harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals allergic to this medication or its ingredients, pregnant or breastfeeding women, patients with severely impaired liver function, those with hereditary angioedema, and patients with certain renal diseases or diabetes. Elderly individuals or those with high potassium levels in the blood, liver or heart disease, or impaired kidney function require special caution when using this medication. While taking this medicine, regular checks of blood pressure, kidney function, and electrolyte levels are necessary to detect adverse reactions early and respond accordingly. Rarely, serious side effects such as angioedema, hyperkalemia, worsening of kidney function, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, so consult a healthcare professional immediately if such symptoms appear. When used in conjunction with other antihypertensive drugs, the blood pressure-lowering effect may be increased, and the risk of renal function impairment and hyperkalemia may be heightened, so caution is advised when combining therapies. Specifically, the concurrent use of this medication with ACE inhibitors or aliskiren is not recommended, and when used with lithium preparations, serum lithium levels should be monitored closely. It is advisable not to administer this medication within 24 hours prior to surgery, and overdose may cause hypotension, dizziness, and acute renal failure, necessitating immediate treatment. The safety and efficacy of this medication in children have not been established, so it is best avoided in pediatric use. When driving or operating machinery, caution is advised as dizziness or fainting may occur due to the effects of this medication.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attack, respiratory distress accompanied by cough and fever, breathing problems, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormality (jaundice), sudden

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius at room temperature.

Appearance

White oblong tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle